skip to main content
Idioma:
Refinado por: assunto: Lung Neoplasms - Mortality remover Aged remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
A Randomized Phase II Pharmacokinetic and Pharmacodynamic Study of Indisulam as Second-Line Therapy in Patients with Advanced Non–Small Cell Lung Cancer
A Randomized Phase II Pharmacokinetic and Pharmacodynamic Study of Indisulam as Second-Line Therapy in Patients with Advanced Non–Small Cell Lung Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

A Randomized Phase II Pharmacokinetic and Pharmacodynamic Study of Indisulam as Second-Line Therapy in Patients with Advanced Non–Small Cell Lung Cancer

TALBOT, Denis C ; VON PAWEL, Joachim ; RECK, Martin ; CATTELL, Emma ; YULE, S. Murray ; JOHNSTON, Claire ; ZANDVLIET, Anthe S ; HUITEMA, Alwin D. R ; NORBURY, Chris J ; ELLIS, Paul ; BOSQUEE, Leon

Clinical cancer research, 2007-03, Vol.13 (6), p.1816-1822 [Periódico revisado por pares]

Philadelphia, PA: American Association for Cancer Research

Texto completo disponível

Citações Citado por
2
A randomized phase II study of bortezomib and pemetrexed, in combination or alone, in patients with previously treated advanced non-small-cell lung cancer
A randomized phase II study of bortezomib and pemetrexed, in combination or alone, in patients with previously treated advanced non-small-cell lung cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

A randomized phase II study of bortezomib and pemetrexed, in combination or alone, in patients with previously treated advanced non-small-cell lung cancer

Scagliotti, Giorgio V ; Germonpré, Paul ; Bosquée, Leon ; Vansteenkiste, Johan ; Gervais, R ; Planchard, David ; Reck, Martin ; De Marinis, Filippo ; Lee, Jin Soo ; Park, Keunchil ; Biesma, Bonne ; Gans, Steven ; Ramlau, R ; Szczesna, Aleusandra ; Makhson, A ; Manikhas, G ; Morgan, Bruno ; Zhu, Y ; Chan, Kai C ; von Pawel, Joachim

Lung cancer (Amsterdam, Netherlands), 2010-06, Vol.68 (3), p.420-426 [Periódico revisado por pares]

Oxford: Elsevier Ireland Ltd

Texto completo disponível

Citações Citado por
3
Baseline quality of life and performance status as prognostic factors in patients with extensive-stage disease small cell lung cancer treated with pemetrexed plus carboplatin vs. etoposide plus carboplatin
Baseline quality of life and performance status as prognostic factors in patients with extensive-stage disease small cell lung cancer treated with pemetrexed plus carboplatin vs. etoposide plus carboplatin
Material Type:
Artigo 		Adicionar ao Meu Espaço

Baseline quality of life and performance status as prognostic factors in patients with extensive-stage disease small cell lung cancer treated with pemetrexed plus carboplatin vs. etoposide plus carboplatin

Reck, Martin ; Thatcher, Nick ; Smit, Egbert F ; Lorigan, Paul ; Szutowicz-Zielinska, Ewa ; Liepa, Astra M ; Winfree, Katherine B ; Peterson, Patrick ; Guba, Susan C ; Socinski, Mark A

Lung cancer (Amsterdam, Netherlands), 2012-12, Vol.78 (3), p.276-281 [Periódico revisado por pares]

Oxford: Elsevier Ireland Ltd

Texto completo disponível

Citações Citado por
4
Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer
Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer

Antonia, Scott J ; Villegas, Augusto ; Daniel, Davey ; Vicente, David ; Murakami, Shuji ; Hui, Rina ; Yokoi, Takashi ; Chiappori, Alberto ; Lee, Ki H ; de Wit, Maike ; Cho, Byoung C ; Bourhaba, Maryam ; Quantin, Xavier ; Tokito, Takaaki ; Mekhail, Tarek ; Planchard, David ; Kim, Young-Chul ; Karapetis, Christos S ; Hiret, Sandrine ; Ostoros, Gyula ; Kubota, Kaoru ; Gray, Jhanelle E ; Paz-Ares, Luis ; de Castro Carpeño, Javier ; Wadsworth, Catherine ; Melillo, Giovanni ; Jiang, Haiyi ; Huang, Yifan ; Dennis, Phillip A ; Özgüroğlu, Mustafa

The New England journal of medicine, 2017-11, Vol.377 (20), p.1919-1929 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
5
Efficacy of a toxicity-adjusted topotecan therapy in recurrent small cell lung cancer
Efficacy of a toxicity-adjusted topotecan therapy in recurrent small cell lung cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy of a toxicity-adjusted topotecan therapy in recurrent small cell lung cancer

Huber, R. M ; Reck, M ; Gosse, H ; von Pawel, J ; Mezger, J ; Saal, J. G ; Kleinschmidt, R ; Steppert, C ; Steppling, H

The European respiratory journal, 2006-06, Vol.27 (6), p.1183-1189 [Periódico revisado por pares]

Leeds: Eur Respiratory Soc

Texto completo disponível

Citações Citado por
6
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer

Horn, Leora ; Mansfield, Aaron S ; Szczęsna, Aleksandra ; Havel, Libor ; Krzakowski, Maciej ; Hochmair, Maximilian J ; Huemer, Florian ; Losonczy, György ; Johnson, Melissa L ; Nishio, Makoto ; Reck, Martin ; Mok, Tony ; Lam, Sivuonthanh ; Shames, David S ; Liu, Juan ; Ding, Beiying ; Lopez-Chavez, Ariel ; Kabbinavar, Fairooz ; Lin, Wei ; Sandler, Alan ; Liu, Stephen V

The New England journal of medicine, 2018-12, Vol.379 (23), p.2220-2229 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
7
Gefitinib Versus Vinorelbine in Chemotherapy-Naïve Elderly Patients With Advanced Non–Small-Cell Lung Cancer (INVITE): A Randomized, Phase II Study
Gefitinib Versus Vinorelbine in Chemotherapy-Naïve Elderly Patients With Advanced Non–Small-Cell Lung Cancer (INVITE): A Randomized, Phase II Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Gefitinib Versus Vinorelbine in Chemotherapy-Naïve Elderly Patients With Advanced Non–Small-Cell Lung Cancer (INVITE): A Randomized, Phase II Study

CRINO, Lucio ; CAPPUZZO, Federico ; DUFFIELD, Emma L ; ARMOUR, Alison A ; SPEAKE, Georgina ; CULLEN, Michael ; ZATLOUKAL, Petr ; RECK, Martin ; PESEK, Milos ; THOMPSON, Joyce C ; FORD, Hugo E. R ; HIRSCH, Fred R ; VARELLA-GARCIA, Marileila ; GHIORGHIU, Serban

Journal of clinical oncology, 2008-09, Vol.26 (26), p.4253-4260 [Periódico revisado por pares]

Baltimore, MD: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
8
Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial
Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial

Brahmer, Julie R ; Rodríguez-Abreu, Delvys ; Robinson, Andrew G ; Hui, Rina ; Csőszi, Tibor ; Fülöp, Andrea ; Gottfried, Maya ; Peled, Nir ; Tafreshi, Ali ; Cuffe, Sinead ; O'Brien, Mary ; Rao, Suman ; Hotta, Katsuyuki ; Zhang, Jin ; Lubiniecki, Gregory M ; Deitz, Anne C ; Rangwala, Reshma ; Reck, Martin

The lancet oncology, 2017-12, Vol.18 (12), p.1600-1609 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
9
Impact of surgery on survival in palliative patients with metastatic colorectal cancer after first line treatment with weekly 24-hour infusion of high-dose 5-fluorouracil and folinic acid
Impact of surgery on survival in palliative patients with metastatic colorectal cancer after first line treatment with weekly 24-hour infusion of high-dose 5-fluorouracil and folinic acid
Material Type:
Artigo 		Adicionar ao Meu Espaço

Impact of surgery on survival in palliative patients with metastatic colorectal cancer after first line treatment with weekly 24-hour infusion of high-dose 5-fluorouracil and folinic acid

Wein, A. ; Riedel, C. ; Köckerling, F. ; Martus, P. ; Baum, U. ; Brueckl, W. M. ; Reck, T. ; Ott, R. ; Hänsler, J. ; Bernatik, T. ; Becker, D. ; Schneider, T. ; Hohenberger, W. ; Hahn, E. G.

Annals of oncology, 2001-12, Vol.12 (12), p.1721-1727 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por
10
Maintenance bevacizumab–pemetrexed after first-line cisplatin–pemetrexed–bevacizumab for advanced nonsquamous nonsmall-cell lung cancer: updated survival analysis of the AVAPERL (MO22089) randomized phase III trial
Maintenance bevacizumab–pemetrexed after first-line cisplatin–pemetrexed–bevacizumab for advanced nonsquamous nonsmall-cell lung cancer: updated survival analysis of the AVAPERL (MO22089) randomized phase III trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Maintenance bevacizumab–pemetrexed after first-line cisplatin–pemetrexed–bevacizumab for advanced nonsquamous nonsmall-cell lung cancer: updated survival analysis of the AVAPERL (MO22089) randomized phase III trial

Barlesi, F. ; Scherpereel, A. ; Gorbunova, V. ; Gervais, R. ; Vikström, A. ; Chouaid, C. ; Chella, A. ; Kim, J.H. ; Ahn, M.J. ; Reck, M. ; Pazzola, A. ; Kim, H.T. ; Aerts, J.G ; Morando, C. ; Loundou, A. ; Groen, H.J.M. ; Rittmeyer, A.

Annals of oncology, 2014-05, Vol.25 (5), p.1044-1052 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de2006  (2)
  2. 2006Até2007  (2)
  3. 2008Até2011  (3)
  4. 2012Até2015  (6)
  5. Após 2015  (8)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (20)
  2. Japonês  (5)
  3. Russo  (1)
  4. Alemão  (1)
  5. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.